Quantcast

Latest Transplantation medicine Stories

2014-06-04 08:31:48

LONDON, June 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: European Markets for Orthopedic Biomaterialshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/european_markets_orthopedic_biomaterials.html The European orthopedic biomaterials market is expected to reach EUR376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment.The European orthopedic biomaterials market includes bone graft substitutes (BGS),...

2014-06-03 16:25:04

HORSHOLM, Denmark, June 3, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the hiring of senior level management in preparation for potential U.S. commercialization of Envarsus(®) XR (tacrolimus extended-release tablets) an investigational new drug under FDA review for the prevention of organ rejection in adult kidney transplant patients. Key points: -- Envarsus( )XR is an extended release formulation of tacrolimus being designed for once-daily...

2014-05-28 12:32:53

LONDON, May 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: MediPoint: Bone Grafts and Substitutes - US Analysis and Market Forecastshttp://www.reportbuyer.com/pharma_healthcare/treatments/orthopaedic/medipoint_bone_grafts_substitutes_us_analysis_market_forecasts.html MediPoint: Bone Grafts and Substitutes - US Analysis and Market Forecasts SummaryAlthough autograft is still perceived as the gold-standard material in bone grafting, the wide array of...

2014-05-22 04:21:28

HORSHOLM, Denmark, May 22, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Envarsus® for the prevention of organ rejection in adult transplant patients in the European Union (EU). The positive opinion is for both kidney and liver transplant recipients and includes both the...

2014-05-20 16:23:32

MARIETTA, Ga., May 20, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today it has declined to participate in the adjudication of an advertising challenge filed with the National Advertising Division of the Council of Better Business Bureaus (NAD). The NAD administers a self-regulation program designed to ensure the...

2014-05-14 12:32:12

LONDON, May 14, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:MediPoint: Bone Grafts and Substitutes - Global Analysis and Market Forecastshttp://www.reportbuyer.com/pharma_healthcare/treatments/orthopaedic/medipoint_bone_grafts_substitutes_global_analysis_market_forecasts.htmlMediPoint: Bone Grafts and Substitutes - Global Analysis and Market ForecastsSummaryAlthough autograft is still perceived as the gold-standard material in bone grafting, the wide...

2014-05-09 23:04:31

Transparency Market Research published a new report "Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Albany, New York (PRWEB) May 09, 2014 According to a new market report published by Transparency Market Research "Organ Preservation Solutions Market (By Solutions-Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and...

2014-05-09 20:22:24

Gase, a NASCAR Nationwide Series Driver, raises awareness about organ, eye and tissue donation by driving the Donate Life® racecar CENTENNIAL, Colo., May 9, 2014 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, hosted Joey Gase, a NASCAR Nationwide Series Driver and donor son, with the Limb Preservation...

2014-05-09 16:24:29

New Technique Expands Number of Functional Cord Blood Stem Cells for Transplantation NEW YORK, May 9, 2014 /PRNewswire-USNewswire/ -- Adults suffering from diseases such as leukemia, lymphoma, and other blood-related disorders may benefit from life-saving treatment commonly used in pediatric patients. Researchers at the Icahn School of Medicine at Mount Sinai have identified a new technique that causes cord blood (CB) stems cells to generate in greater numbers making them more useful...

2014-05-08 16:25:55

DUBLIN, May 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/skjt47/global_and) has announced the addition of the "Global and Chinese Vascular Graft Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769The Global and Chinese Vascular Graft Industry Report 2014 is a professional and in-depth study on the current state of the global vascular graft industry with a focus on the Chinese situation.The...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related